Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
It is the first triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, a mechanism that produced 24.2% mean body weight reduction in Phase 2 trials and a staggering 28.7% in Phase 3 data
Common side effects may include: Rare but possible risks include: Our providers monitor every patient closely and adjust treatment as needed to minimize risks
You should consult your healthcare provider first to discuss how to safely switch between medications
Who can take them: Both Ozempic and Zepbound can be prescribed for weight loss to people who meet certain BMI thresholds
Your body has fewer resources available for tissue repair, inflammation resolution, and adaptation to training stress
US$ 22.57
US$ 21.51
US$ 27.14
US$ 22.80
US$ 28.92
